Total Gallium is GE Healthcare's cyclotron-produced Gallium 68 supply solution that provides a cost-effective, predictable alternative to generator-supplied Gallium 68 for prostate cancer research and clinical therapy. It is an integrated suite of technologies and support that ensures a consistent and reliable supply of Gallium 68 tracers to meet your clinical and research needs.

GE has been an active member of the Molecular Imaging community and helping to drive progress, together with our users, toward a technological innovation to enable an alternative source of Gallium 68 tracers. We can help provide subject matter expertise in the implementation of Total Gallium technologies, as well as provide regulatory support to smoothly enable your compliant and clinical production of cyclotron Gallium 68 tracers.